CONSULTING AGREEMENTConsulting Agreement • July 13th, 2021 • Immunovant, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJuly 13th, 2021 Company Industry JurisdictionTHIS CONSULTING AGREEMENT (this “Agreement”) is made and entered into as of July 13, 2021 by and between Immunovant, Inc. (“Immunovant”) and Pamela Yanchik Connealy (“Consultant”). Immunovant and Consultant may be referred to herein individually as a “Party” and collectively as the “Parties.”